Novo Nordisk

S01E95 : DIABESITY ECOSYSTEM 1/3 : NOVO NORDISK

File open 18 September 2026: Novo Nordisk / Diabesity Ecosystem.

Listen on

Listen (episode)Spotify Apple Podcasts RSS

The Cassandra Files — forensic audio drama. Katie audits the books, Marcus kills the spin, Killian opens the file. About · Latest · Themes

THE FILE

The archive opens on 18 September 2026. Q3 is bleeding out, and the ledger demands its toll. Today’s file isolates Novo Nordisk and the engineered architecture of the diabesity ecosystem. We are tracking the exact price of a functioning pancreas.

THE THEME

The modern food supply broke the human endocrine system, and the pharmaceutical industry built a toll booth on the wreckage. This is the metabolic debt of the retail food pivot, masked as a synthetic miracle. GLP-1 receptor agonists are no longer just medicine; they are a monthly subscription model for basic biological survival. As insurance coverage fractures, the human body becomes a permanent, captive revenue stream.

THE ROOM

Katie’s fountain pen rests parallel to the desk edge, perfectly insulated by the clinical data. Marcus rubs at his neck, feeling the phantom ache of a bad biological debt. Step inside and hit play.

NOTES: ABB: ABB’s Multipolar Grift: Precision Traded for Bulk

A critical examination of ABB's local-for-local supply chain strategy, revealing the persistent vulnerabilities and foreign raw material dependencies hidden behind domestic assembly.

AUDIT: ABB: The Multipolar Illusion: Financing the Localized Grid

An objective analysis of ABB's $110 million localized manufacturing expansion and its strategic realignment toward domestic value capture amid surging data center demand.

S01E113 : MULTIPOLAR SUPPLY 1/1 : ABB

16 October 2026: ABB sells off its robotics future to SoftBank to fund a localized electrification grift. Peeling back the drywall on the corporate bait-and-switch funding the grid.

S01E110 : MULTIPOLAR SUPPLY 2/3 : INTEL / SAMSUNG

14 October 2026: The geopolitical panic room opens in Cupertino. As Apple attempts to untangle its absolute reliance on TSMC, we examine the billion-dollar gamble on Intel and Samsung's secondary foundries.